GSK3B and urinary bladder cancer: These results suggest that the expression of the amino-truncated form of NOV is potentially responsible for enhancing the progression and chemoresistance of bladder cancer by inducing EMT and enhancing the serine phosphorylation of GSK-3β and β-catenin.